SPL Starpharma Holdings Limited
—Mkt Cap: —P/E: —1d ago
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applicatio…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value240.03M USD
Revenue (TTM)8.75M USD
Gross Profit7.81M USD
Net Income (TTM)-5.16M USD
Revenue/Share0.03 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees50
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000SPL0
Valuation
P/E (Trailing)—
P/E (Forward)166.67
PEG—
EV/EBITDA-48.40
EV/Revenue27.42
P/S28.40
P/B22.73
EPS (TTM)-0.02
EPS (Forward)0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin93.82%
Oper. Margin-583.74%
EBITDA Margin-56.66%
Profit Margin-61.95%
ROE-54.19%
ROA-39.25%
Growth
Revenue Growth-55.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.22M USD
CapEx (TTM)198.34K USD
FCF Margin-5.59%
FCF Yield—
Net Debt-7.12M USD
Net Debt/EBITDA1.44
Balance Sheet
Debt/Equity0.05
Current Ratio3.40
Quick Ratio2.98
Book Value/Sh0.03 AUD
Cash/Share0.02 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div DateMar 25, 1988
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.220 AUD
Target Range1.190 AUD – 1.250 AUD
# Analysts2
Ownership
Shares Out.479.74M
Float352.87M
Insiders30.84%
Institutions16.85%
Technical
SMA 500.7727 AUD
SMA 2000.6261 AUD
Beta0.72
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)2.25M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—